

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | DNA deamination (GO:0045006) | 7.13131275 |
| 2 | telomere maintenance via semi-conservative replication (GO:0032201) | 6.23396770 |
| 3 | nuclear pore complex assembly (GO:0051292) | 5.95852954 |
| 4 | nuclear pore organization (GO:0006999) | 5.68492600 |
| 5 | DNA strand elongation involved in DNA replication (GO:0006271) | 5.45045932 |
| 6 | telomere maintenance via recombination (GO:0000722) | 5.32284365 |
| 7 | DNA strand elongation (GO:0022616) | 5.21733769 |
| 8 | negative regulation of transcription by competitive promoter binding (GO:0010944) | 5.10831591 |
| 9 | DNA replication initiation (GO:0006270) | 5.06327699 |
| 10 | negative regulation of myotube differentiation (GO:0010832) | 4.98813757 |
| 11 | * ribosome assembly (GO:0042255) | 4.90786410 |
| 12 | negative regulation of granulocyte differentiation (GO:0030853) | 4.80749422 |
| 13 | GDP-mannose metabolic process (GO:0019673) | 4.70712439 |
| 14 | respiratory chain complex IV assembly (GO:0008535) | 4.63348896 |
| 15 | mitotic recombination (GO:0006312) | 4.60909455 |
| 16 | ribosomal small subunit assembly (GO:0000028) | 4.48929433 |
| 17 | myeloid leukocyte mediated immunity (GO:0002444) | 4.37019063 |
| 18 | telomere maintenance via telomere lengthening (GO:0010833) | 4.36617086 |
| 19 | pore complex assembly (GO:0046931) | 4.23708409 |
| 20 | neutrophil mediated immunity (GO:0002446) | 4.12929485 |
| 21 | regulation of cellular respiration (GO:0043457) | 4.07390054 |
| 22 | mitotic sister chromatid cohesion (GO:0007064) | 3.94743494 |
| 23 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 3.94009133 |
| 24 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 3.94009133 |
| 25 | dolichol-linked oligosaccharide biosynthetic process (GO:0006488) | 3.88051434 |
| 26 | mitotic nuclear envelope disassembly (GO:0007077) | 3.79357295 |
| 27 | mitotic metaphase plate congression (GO:0007080) | 3.77755759 |
| 28 | cytochrome complex assembly (GO:0017004) | 3.73642333 |
| 29 | mannosylation (GO:0097502) | 3.73573984 |
| 30 | folic acid-containing compound biosynthetic process (GO:0009396) | 3.72463023 |
| 31 | negative regulation of phagocytosis (GO:0050765) | 3.72353242 |
| 32 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 3.71103643 |
| 33 | IMP biosynthetic process (GO:0006188) | 3.64572528 |
| 34 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 3.63134281 |
| 35 | mitochondrion degradation (GO:0000422) | 3.62854476 |
| 36 | cotranslational protein targeting to membrane (GO:0006613) | 3.59621823 |
| 37 | DNA replication checkpoint (GO:0000076) | 3.58283075 |
| 38 | protein targeting to ER (GO:0045047) | 3.56351329 |
| 39 | negative regulation of growth of symbiont in host (GO:0044130) | 3.54609604 |
| 40 | negative regulation of growth of symbiont involved in interaction with host (GO:0044146) | 3.54609604 |
| 41 | modulation of growth of symbiont involved in interaction with host (GO:0044144) | 3.54609604 |
| 42 | regulation of growth of symbiont in host (GO:0044126) | 3.54609604 |
| 43 | regulation of centriole replication (GO:0046599) | 3.53906551 |
| 44 | membrane invagination (GO:0010324) | 3.50221714 |
| 45 | sister chromatid segregation (GO:0000819) | 3.48776057 |
| 46 | membrane disassembly (GO:0030397) | 3.48492439 |
| 47 | nuclear envelope disassembly (GO:0051081) | 3.48492439 |
| 48 | positive regulation of histone H3-K4 methylation (GO:0051571) | 3.47650525 |
| 49 | mitotic chromosome condensation (GO:0007076) | 3.46366969 |
| 50 | tongue development (GO:0043586) | 3.45236469 |
| 51 | cullin deneddylation (GO:0010388) | 3.43745365 |
| 52 | pseudouridine synthesis (GO:0001522) | 3.43099844 |
| 53 | protein localization to endoplasmic reticulum (GO:0070972) | 3.43063823 |
| 54 | viral transcription (GO:0019083) | 3.42134349 |
| 55 | mitotic G2/M transition checkpoint (GO:0044818) | 3.40946258 |
| 56 | nucleotide-excision repair, DNA gap filling (GO:0006297) | 3.40215630 |
| 57 | regulation of translational fidelity (GO:0006450) | 3.38641094 |
| 58 | proteasome assembly (GO:0043248) | 3.37567793 |
| 59 | mitotic sister chromatid segregation (GO:0000070) | 3.37277874 |
| 60 | mitotic G2 DNA damage checkpoint (GO:0007095) | 3.36855163 |
| 61 | translational termination (GO:0006415) | 3.35116806 |
| 62 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 3.34575645 |
| 63 | protein localization to kinetochore (GO:0034501) | 3.34516837 |
| 64 | nuclear-transcribed mRNA poly(A) tail shortening (GO:0000289) | 3.30485846 |
| 65 | metaphase plate congression (GO:0051310) | 3.29974460 |
| 66 | establishment of integrated proviral latency (GO:0075713) | 3.26335184 |
| 67 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.25238435 |
| 68 | protein localization to chromosome, centromeric region (GO:0071459) | 3.22727841 |
| 69 | non-recombinational repair (GO:0000726) | 3.17016028 |
| 70 | double-strand break repair via nonhomologous end joining (GO:0006303) | 3.17016028 |
| 71 | signal peptide processing (GO:0006465) | 3.16881581 |
| 72 | tRNA aminoacylation for protein translation (GO:0006418) | 3.16830184 |
| 73 | DNA topological change (GO:0006265) | 3.16013670 |
| 74 | C-terminal protein lipidation (GO:0006501) | 3.12086710 |
| 75 | synapsis (GO:0007129) | 3.12059687 |
| 76 | tRNA aminoacylation (GO:0043039) | 3.11382719 |
| 77 | amino acid activation (GO:0043038) | 3.11382719 |
| 78 | nucleobase biosynthetic process (GO:0046112) | 3.10628731 |
| 79 | protein deneddylation (GO:0000338) | 3.09752657 |
| 80 | mitotic spindle checkpoint (GO:0071174) | 3.03272109 |
| 81 | positive regulation of protein export from nucleus (GO:0046827) | 3.03227830 |
| 82 | positive regulation of mitotic metaphase/anaphase transition (GO:0045842) | 3.02823862 |
| 83 | positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101) | 3.02823862 |
| 84 | positive regulation of mitotic sister chromatid separation (GO:1901970) | 3.02823862 |
| 85 | telomere maintenance (GO:0000723) | 3.02816139 |
| 86 | regulation of attachment of spindle microtubules to kinetochore (GO:0051988) | 3.02271960 |
| 87 | translational elongation (GO:0006414) | 3.02070307 |
| 88 | telomere organization (GO:0032200) | 3.01084003 |
| 89 | ribosomal large subunit biogenesis (GO:0042273) | 2.98663702 |
| 90 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 2.96760314 |
| 91 | attachment of spindle microtubules to kinetochore (GO:0008608) | 2.94895854 |
| 92 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 2.94701271 |
| 93 | DNA replication-dependent nucleosome assembly (GO:0006335) | 2.93868632 |
| 94 | DNA replication-dependent nucleosome organization (GO:0034723) | 2.93868632 |
| 95 | purine nucleobase biosynthetic process (GO:0009113) | 2.93706519 |
| 96 | positive regulation of gluconeogenesis (GO:0045722) | 2.92788456 |
| 97 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 2.91147201 |
| 98 | establishment of chromosome localization (GO:0051303) | 2.90400297 |
| 99 | regulation of metaphase/anaphase transition of cell cycle (GO:1902099) | 2.90059261 |
| 100 | regulation of mitotic metaphase/anaphase transition (GO:0030071) | 2.90059261 |
| 101 | ribonucleoprotein complex disassembly (GO:0032988) | 2.89969596 |
| 102 | ribosomal small subunit biogenesis (GO:0042274) | 2.89896191 |
| 103 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 2.88902049 |
| 104 | formation of translation preinitiation complex (GO:0001731) | 2.88553627 |
| 105 | killing of cells of other organism (GO:0031640) | 2.88504008 |
| 106 | disruption of cells of other organism (GO:0044364) | 2.88504008 |
| 107 | spindle checkpoint (GO:0031577) | 2.88486816 |
| 108 | nucleobase-containing small molecule interconversion (GO:0015949) | 2.87576659 |
| 109 | translation (GO:0006412) | 2.86279349 |
| 110 | maturation of 5.8S rRNA (GO:0000460) | 2.85935183 |
| 111 | intra-S DNA damage checkpoint (GO:0031573) | 2.85027534 |
| 112 | maturation of SSU-rRNA (GO:0030490) | 2.84807619 |
| 113 | kinetochore organization (GO:0051383) | 2.83506215 |
| 114 | regulation of translational initiation (GO:0006446) | 2.83494991 |
| 115 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 2.81797933 |
| 116 | regulation of centrosome cycle (GO:0046605) | 2.81516928 |
| 117 | negative regulation of mitotic metaphase/anaphase transition (GO:0045841) | 2.81383318 |
| 118 | negative regulation of metaphase/anaphase transition of cell cycle (GO:1902100) | 2.81383318 |
| 119 | negative regulation of mitotic sister chromatid segregation (GO:0033048) | 2.81383318 |
| 120 | negative regulation of mitotic sister chromatid separation (GO:2000816) | 2.81383318 |
| 121 | negative regulation of sister chromatid segregation (GO:0033046) | 2.81383318 |
| 122 | regulation of translational termination (GO:0006449) | 2.81098346 |
| 123 | regulation of mitotic sister chromatid separation (GO:0010965) | 2.80779280 |
| 124 | regulation of mitotic sister chromatid segregation (GO:0033047) | 2.80779280 |
| 125 | regulation of sister chromatid segregation (GO:0033045) | 2.80779280 |
| 126 | regulation of chromosome segregation (GO:0051983) | 2.79829128 |
| 127 | DNA catabolic process, exonucleolytic (GO:0000738) | 2.79714499 |
| 128 | negative regulation of chromosome segregation (GO:0051985) | 2.79414993 |
| 129 | positive regulation of chromosome segregation (GO:0051984) | 2.79378354 |
| 130 | mitotic spindle assembly checkpoint (GO:0007094) | 2.79171427 |
| 131 | IMP metabolic process (GO:0046040) | 2.78668453 |
| 132 | organelle disassembly (GO:1903008) | 2.77816401 |
| 133 | cellular protein complex localization (GO:0034629) | 2.76419543 |
| 134 | regulation of histone H3-K9 methylation (GO:0051570) | 2.76108603 |
| 135 | spindle assembly checkpoint (GO:0071173) | 2.75722163 |
| 136 | chromosome segregation (GO:0007059) | 2.75539890 |
| 137 | DNA double-strand break processing (GO:0000729) | 2.75410000 |
| 138 | DNA ligation (GO:0006266) | 2.74804513 |
| 139 | DNA replication-independent nucleosome organization (GO:0034724) | 2.74081284 |
| 140 | DNA replication-independent nucleosome assembly (GO:0006336) | 2.74081284 |
| 141 | somatic diversification of immunoglobulins involved in immune response (GO:0002208) | 2.73947487 |
| 142 | isotype switching (GO:0045190) | 2.73947487 |
| 143 | somatic recombination of immunoglobulin genes involved in immune response (GO:0002204) | 2.73947487 |
| 144 | response to fungus (GO:0009620) | 2.71429664 |
| 145 | DNA unwinding involved in DNA replication (GO:0006268) | 2.70986481 |
| 146 | protein heterotetramerization (GO:0051290) | 2.70839626 |
| 147 | ribonucleoprotein complex biogenesis (GO:0022613) | 2.69639800 |
| 148 | defense response to fungus (GO:0050832) | 2.69232408 |
| 149 | CENP-A containing nucleosome assembly (GO:0034080) | 2.69215583 |
| 150 | G1/S transition of mitotic cell cycle (GO:0000082) | 2.68486499 |
| 151 | cell cycle G1/S phase transition (GO:0044843) | 2.68486499 |
| 152 | regulation of nuclear cell cycle DNA replication (GO:0033262) | 2.68241918 |
| 153 | regulation of type B pancreatic cell apoptotic process (GO:2000674) | 2.67371718 |
| 154 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.66626005 |
| 155 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 2.64691738 |
| 156 | regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083) | 2.64650207 |
| 157 | regulation of double-strand break repair via homologous recombination (GO:0010569) | 2.64384281 |
| 158 | chromatin remodeling at centromere (GO:0031055) | 2.64024703 |
| 159 | regulation of cellular amino acid metabolic process (GO:0006521) | 2.62760485 |
| 160 | * translational initiation (GO:0006413) | 2.62519723 |
| 161 | neutrophil activation involved in immune response (GO:0002283) | 2.62426923 |
| 162 | response to interferon-beta (GO:0035456) | 2.62052593 |
| 163 | response to interferon-alpha (GO:0035455) | 2.61860152 |
| 164 | C-terminal protein amino acid modification (GO:0018410) | 2.57615477 |
| 165 | rRNA processing (GO:0006364) | 2.57483458 |
| 166 | regulation of granulocyte differentiation (GO:0030852) | 2.56976715 |
| 167 | positive regulation of glycoprotein biosynthetic process (GO:0010560) | 2.55916304 |
| 168 | response to peptidoglycan (GO:0032494) | 2.54913409 |
| 169 | viral genome replication (GO:0019079) | 2.54448187 |
| 170 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 2.54121853 |
| 171 | mast cell activation (GO:0045576) | 2.53882720 |
| 172 | facial nerve structural organization (GO:0021612) | 2.53471907 |
| 173 | ribosome biogenesis (GO:0042254) | 2.53192738 |
| 174 | lymphoid progenitor cell differentiation (GO:0002320) | 2.52833234 |
| 175 | positive regulation of cellular amine metabolic process (GO:0033240) | 2.52636173 |
| 176 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 2.52415320 |
| 177 | generation of neurons (GO:0048699) | 2.52086209 |
| 178 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 2.51936198 |
| 179 | deoxyribonucleotide biosynthetic process (GO:0009263) | 2.50485950 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 7.02276324 |
| 2 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.92346985 |
| 3 | * MYC_18555785_ChIP-Seq_MESCs_Mouse | 3.73017690 |
| 4 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.71588074 |
| 5 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 3.36359077 |
| 6 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 3.34299213 |
| 7 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 3.25060413 |
| 8 | * GABP_17652178_ChIP-ChIP_JURKAT_Human | 3.14061395 |
| 9 | * JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 3.11830441 |
| 10 | * MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.84907528 |
| 11 | * EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.81990212 |
| 12 | * KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 2.78579501 |
| 13 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.77882480 |
| 14 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.71775256 |
| 15 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.64346465 |
| 16 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.58246251 |
| 17 | * MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.45837346 |
| 18 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.42854578 |
| 19 | * TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.33108822 |
| 20 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 2.32205991 |
| 21 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.29427984 |
| 22 | * VDR_23849224_ChIP-Seq_CD4+_Human | 2.27191349 |
| 23 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.25558858 |
| 24 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 2.22811509 |
| 25 | * HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.22670026 |
| 26 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.18962396 |
| 27 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.12507333 |
| 28 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 2.04631691 |
| 29 | * PADI4_21655091_ChIP-ChIP_MCF-7_Human | 2.02203058 |
| 30 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.01770715 |
| 31 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.99747869 |
| 32 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.98775048 |
| 33 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.97731941 |
| 34 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.97346193 |
| 35 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.95448205 |
| 36 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.94564918 |
| 37 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.93936935 |
| 38 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.93196598 |
| 39 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.91412540 |
| 40 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.88574632 |
| 41 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.85001646 |
| 42 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.83552235 |
| 43 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.82960754 |
| 44 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.81873443 |
| 45 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.78437359 |
| 46 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.77789941 |
| 47 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.71146249 |
| 48 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.69864063 |
| 49 | * ELK1_19687146_ChIP-ChIP_HELA_Human | 1.67814268 |
| 50 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.64716071 |
| 51 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.64536294 |
| 52 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.64281132 |
| 53 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.63500544 |
| 54 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.63443403 |
| 55 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.63254042 |
| 56 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.62209435 |
| 57 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.60816442 |
| 58 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.60461340 |
| 59 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.59789369 |
| 60 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.56831129 |
| 61 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.56663278 |
| 62 | MYC_22102868_ChIP-Seq_BL_Human | 1.56419394 |
| 63 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.54126767 |
| 64 | GATA1_22025678_ChIP-Seq_K562_Human | 1.48152906 |
| 65 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.46310845 |
| 66 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.46183916 |
| 67 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.37355490 |
| 68 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.36872534 |
| 69 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.32018507 |
| 70 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.31629047 |
| 71 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.29632550 |
| 72 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.29108663 |
| 73 | * CREM_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.27369268 |
| 74 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.26641469 |
| 75 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.25307488 |
| 76 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.24902116 |
| 77 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.24603162 |
| 78 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.22056466 |
| 79 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.21991377 |
| 80 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.21348761 |
| 81 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.21034251 |
| 82 | EWS_26573619_Chip-Seq_HEK293_Human | 1.20595230 |
| 83 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.18712806 |
| 84 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.17420164 |
| 85 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.16545226 |
| 86 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.15345970 |
| 87 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.15132633 |
| 88 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.14815153 |
| 89 | MYB_26560356_Chip-Seq_TH2_Human | 1.12600220 |
| 90 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.10450887 |
| 91 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.10395288 |
| 92 | FUS_26573619_Chip-Seq_HEK293_Human | 1.08782066 |
| 93 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.08054640 |
| 94 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.07717590 |
| 95 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 1.07266564 |
| 96 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.07058384 |
| 97 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.05954491 |
| 98 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.04525094 |
| 99 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.02881933 |
| 100 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.01560933 |
| 101 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.01329744 |
| 102 | ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 1.01070920 |
| 103 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.00770497 |
| 104 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.00286917 |
| 105 | SOX17_20123909_ChIP-Seq_XEN_Mouse | 0.98508565 |
| 106 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.97700634 |
| 107 | MYB_26560356_Chip-Seq_TH1_Human | 0.96020534 |
| 108 | AR_21909140_ChIP-Seq_LNCAP_Human | 0.95657427 |
| 109 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 0.95164599 |
| 110 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 0.94471630 |
| 111 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 0.93989530 |
| 112 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.92684111 |
| 113 | MYC_18940864_ChIP-ChIP_HL60_Human | 0.92163289 |
| 114 | SOX2_19030024_ChIP-ChIP_MESCs_Mouse | 0.92112576 |
| 115 | * ELK1_22589737_ChIP-Seq_MCF10A_Human | 0.92058595 |
| 116 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.91648617 |
| 117 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 0.90979427 |
| 118 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 0.90842593 |
| 119 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.90499799 |
| 120 | CHD1_26751641_Chip-Seq_LNCaP_Human | 0.89283681 |
| 121 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.88847728 |
| 122 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.88501556 |
| 123 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.88498439 |
| 124 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.87321730 |
| 125 | ELF5_23300383_ChIP-Seq_T47D_Human | 0.86727977 |
| 126 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.86271180 |
| 127 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 0.85340992 |
| 128 | MAF_26560356_Chip-Seq_TH1_Human | 0.84545545 |
| 129 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.84181266 |
| 130 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.83231508 |
| 131 | VDR_22108803_ChIP-Seq_LS180_Human | 0.79057128 |
| 132 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.77857607 |
| 133 | * CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 0.75174801 |
| 134 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 0.74595102 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0009379_abnormal_foot_pigmentation | 4.72141201 |
| 2 | MP0008260_abnormal_autophagy | 4.32163918 |
| 3 | MP0003693_abnormal_embryo_hatching | 3.32151496 |
| 4 | MP0005174_abnormal_tail_pigmentation | 3.30557727 |
| 5 | MP0003724_increased_susceptibility_to | 3.21297257 |
| 6 | MP0010234_abnormal_vibrissa_follicle | 3.16935026 |
| 7 | MP0000015_abnormal_ear_pigmentation | 2.81274770 |
| 8 | MP0001188_hyperpigmentation | 2.74354672 |
| 9 | MP0009697_abnormal_copulation | 2.73813750 |
| 10 | MP0008058_abnormal_DNA_repair | 2.65201189 |
| 11 | MP0005409_darkened_coat_color | 2.61946166 |
| 12 | MP0002396_abnormal_hematopoietic_system | 2.59192825 |
| 13 | MP0010352_gastrointestinal_tract_polyps | 2.54177972 |
| 14 | MP0010094_abnormal_chromosome_stability | 2.49939174 |
| 15 | MP0003646_muscle_fatigue | 2.48248740 |
| 16 | MP0006292_abnormal_olfactory_placode | 2.29983864 |
| 17 | MP0005075_abnormal_melanosome_morpholog | 2.29472019 |
| 18 | MP0001835_abnormal_antigen_presentation | 2.23378842 |
| 19 | MP0001853_heart_inflammation | 2.20409698 |
| 20 | MP0003436_decreased_susceptibility_to | 2.20173463 |
| 21 | MP0000490_abnormal_crypts_of | 2.12645709 |
| 22 | MP0008057_abnormal_DNA_replication | 2.12246704 |
| 23 | MP0003303_peritoneal_inflammation | 2.07096147 |
| 24 | MP0003763_abnormal_thymus_physiology | 2.05233090 |
| 25 | MP0004957_abnormal_blastocyst_morpholog | 2.04737507 |
| 26 | MP0003111_abnormal_nucleus_morphology | 2.04544666 |
| 27 | MP0009785_altered_susceptibility_to | 2.03051599 |
| 28 | MP0000681_abnormal_thyroid_gland | 2.02503687 |
| 29 | MP0010307_abnormal_tumor_latency | 2.02270059 |
| 30 | MP0009333_abnormal_splenocyte_physiolog | 2.00956492 |
| 31 | MP0003941_abnormal_skin_development | 1.99837140 |
| 32 | MP0003077_abnormal_cell_cycle | 1.97983083 |
| 33 | MP0002166_altered_tumor_susceptibility | 1.97501487 |
| 34 | MP0001730_embryonic_growth_arrest | 1.95245332 |
| 35 | MP0000465_gastrointestinal_hemorrhage | 1.88676103 |
| 36 | MP0002095_abnormal_skin_pigmentation | 1.86844305 |
| 37 | MP0003656_abnormal_erythrocyte_physiolo | 1.84939973 |
| 38 | MP0000350_abnormal_cell_proliferation | 1.83211932 |
| 39 | MP0002419_abnormal_innate_immunity | 1.80339464 |
| 40 | MP0002148_abnormal_hypersensitivity_rea | 1.78855405 |
| 41 | MP0000678_abnormal_parathyroid_gland | 1.76553256 |
| 42 | MP0005025_abnormal_response_to | 1.76512685 |
| 43 | MP0005671_abnormal_response_to | 1.73321379 |
| 44 | MP0003950_abnormal_plasma_membrane | 1.72393430 |
| 45 | MP0005000_abnormal_immune_tolerance | 1.72331005 |
| 46 | MP0002876_abnormal_thyroid_physiology | 1.71981834 |
| 47 | MP0008007_abnormal_cellular_replicative | 1.71590644 |
| 48 | MP0002006_tumorigenesis | 1.66060031 |
| 49 | MP0003806_abnormal_nucleotide_metabolis | 1.64271613 |
| 50 | MP0005380_embryogenesis_phenotype | 1.61011955 |
| 51 | MP0001672_abnormal_embryogenesis/_devel | 1.61011955 |
| 52 | MP0002877_abnormal_melanocyte_morpholog | 1.58211291 |
| 53 | MP0001986_abnormal_taste_sensitivity | 1.57603710 |
| 54 | MP0003890_abnormal_embryonic-extraembry | 1.57250009 |
| 55 | MP0001697_abnormal_embryo_size | 1.56826026 |
| 56 | MP0004782_abnormal_surfactant_physiolog | 1.52186367 |
| 57 | MP0002420_abnormal_adaptive_immunity | 1.51786276 |
| 58 | MP0003984_embryonic_growth_retardation | 1.49924144 |
| 59 | MP0001819_abnormal_immune_cell | 1.49631322 |
| 60 | MP0003186_abnormal_redox_activity | 1.49318831 |
| 61 | MP0002398_abnormal_bone_marrow | 1.47369368 |
| 62 | MP0005464_abnormal_platelet_physiology | 1.46166334 |
| 63 | MP0002088_abnormal_embryonic_growth/wei | 1.46018314 |
| 64 | MP0002723_abnormal_immune_serum | 1.45763027 |
| 65 | MP0000858_altered_metastatic_potential | 1.44485061 |
| 66 | MP0002086_abnormal_extraembryonic_tissu | 1.38937514 |
| 67 | MP0000689_abnormal_spleen_morphology | 1.35404820 |
| 68 | MP0000716_abnormal_immune_system | 1.34742257 |
| 69 | MP0002796_impaired_skin_barrier | 1.33489996 |
| 70 | MP0001873_stomach_inflammation | 1.33321271 |
| 71 | MP0002080_prenatal_lethality | 1.31602813 |
| 72 | MP0000613_abnormal_salivary_gland | 1.31307213 |
| 73 | MP0002722_abnormal_immune_system | 1.26986462 |
| 74 | MP0002452_abnormal_antigen_presenting | 1.26917957 |
| 75 | MP0000372_irregular_coat_pigmentation | 1.26611593 |
| 76 | MP0003786_premature_aging | 1.25236460 |
| 77 | MP0001545_abnormal_hematopoietic_system | 1.25221186 |
| 78 | MP0005397_hematopoietic_system_phenotyp | 1.25221186 |
| 79 | MP0002019_abnormal_tumor_incidence | 1.24212328 |
| 80 | MP0001800_abnormal_humoral_immune | 1.23275409 |
| 81 | MP0002429_abnormal_blood_cell | 1.20851150 |
| 82 | MP0001881_abnormal_mammary_gland | 1.16544303 |
| 83 | MP0005501_abnormal_skin_physiology | 1.14681977 |
| 84 | MP0003183_abnormal_peptide_metabolism | 1.12494560 |
| 85 | MP0002084_abnormal_developmental_patter | 1.12147314 |
| 86 | MP0002751_abnormal_autonomic_nervous | 1.11304017 |
| 87 | MP0000685_abnormal_immune_system | 1.09352437 |
| 88 | MP0001845_abnormal_inflammatory_respons | 1.07695982 |
| 89 | MP0000358_abnormal_cell_content/ | 1.07633444 |
| 90 | MP0004808_abnormal_hematopoietic_stem | 1.06886388 |
| 91 | MP0010155_abnormal_intestine_physiology | 1.04994126 |
| 92 | MP0004185_abnormal_adipocyte_glucose | 1.04066874 |
| 93 | MP0002160_abnormal_reproductive_system | 1.03730376 |
| 94 | MP0008932_abnormal_embryonic_tissue | 1.03532525 |
| 95 | MP0005058_abnormal_lysosome_morphology | 1.03322420 |
| 96 | MP0001661_extended_life_span | 1.01527925 |
| 97 | MP0001929_abnormal_gametogenesis | 1.00425704 |
| 98 | MP0010678_abnormal_skin_adnexa | 0.99936289 |
| 99 | MP0005408_hypopigmentation | 0.99510967 |
| 100 | MP0002009_preneoplasia | 0.98481681 |
| 101 | MP0008995_early_reproductive_senescence | 0.98296799 |
| 102 | MP0001666_abnormal_nutrient_absorption | 0.98186150 |
| 103 | MP0003868_abnormal_feces_composition | 0.96933553 |
| 104 | MP0008469_abnormal_protein_level | 0.94866283 |
| 105 | MP0005076_abnormal_cell_differentiation | 0.94446438 |
| 106 | MP0003172_abnormal_lysosome_physiology | 0.93816974 |
| 107 | MP0001533_abnormal_skeleton_physiology | 0.91757626 |
| 108 | MP0002075_abnormal_coat/hair_pigmentati | 0.91755196 |
| 109 | MP0008877_abnormal_DNA_methylation | 0.90792284 |
| 110 | MP0003866_abnormal_defecation | 0.90504370 |
| 111 | MP0002085_abnormal_embryonic_tissue | 0.89917417 |
| 112 | MP0002210_abnormal_sex_determination | 0.89824110 |
| 113 | MP0006036_abnormal_mitochondrial_physio | 0.89288762 |
| 114 | MP0005451_abnormal_body_composition | 0.88785081 |
| 115 | MP0006035_abnormal_mitochondrial_morpho | 0.88568512 |
| 116 | MP0004197_abnormal_fetal_growth/weight/ | 0.88025184 |
| 117 | MP0002139_abnormal_hepatobiliary_system | 0.87742487 |
| 118 | MP0004264_abnormal_extraembryonic_tissu | 0.87240203 |
| 119 | MP0002132_abnormal_respiratory_system | 0.86246274 |
| 120 | MP0000049_abnormal_middle_ear | 0.86065057 |
| 121 | MP0003221_abnormal_cardiomyocyte_apopto | 0.85410729 |
| 122 | MP0000343_altered_response_to | 0.84380654 |
| 123 | MP0001919_abnormal_reproductive_system | 0.84123462 |
| 124 | MP0001727_abnormal_embryo_implantation | 0.83440459 |
| 125 | MP0000627_abnormal_mammary_gland | 0.81751824 |
| 126 | MP0000703_abnormal_thymus_morphology | 0.81486905 |
| 127 | MP0000371_diluted_coat_color | 0.81197652 |
| 128 | MP0000313_abnormal_cell_death | 0.80453299 |
| 129 | MP0003699_abnormal_female_reproductive | 0.79958167 |
| 130 | MP0002234_abnormal_pharynx_morphology | 0.79784768 |
| 131 | MP0002693_abnormal_pancreas_physiology | 0.78267320 |
| 132 | MP0001764_abnormal_homeostasis | 0.77572625 |
| 133 | MP0001186_pigmentation_phenotype | 0.77526644 |
| 134 | MP0000598_abnormal_liver_morphology | 0.77470470 |
| 135 | MP0001270_distended_abdomen | 0.77373145 |
| 136 | MP0005384_cellular_phenotype | 0.75237479 |
| 137 | MP0001216_abnormal_epidermal_layer | 0.75004203 |
| 138 | MP0000653_abnormal_sex_gland | 0.74687468 |
| 139 | MP0008961_abnormal_basal_metabolism | 0.74657468 |
| 140 | MP0002060_abnormal_skin_morphology | 0.74329133 |
| 141 | MP0005621_abnormal_cell_physiology | 0.74022941 |
| 142 | MP0003943_abnormal_hepatobiliary_system | 0.72986324 |
| 143 | MP0001145_abnormal_male_reproductive | 0.72606679 |
| 144 | MP0005389_reproductive_system_phenotype | 0.72490361 |
| 145 | MP0002405_respiratory_system_inflammati | 0.72453166 |
| 146 | MP0003879_abnormal_hair_cell | 0.71861925 |
| 147 | MP0002177_abnormal_outer_ear | 0.71742114 |
| 148 | MP0002269_muscular_atrophy | 0.71665114 |
| 149 | MP0003718_maternal_effect | 0.71178071 |
| 150 | MP0003567_abnormal_fetal_cardiomyocyte | 0.70745205 |
| 151 | MP0005395_other_phenotype | 0.69605126 |
| 152 | MP0001502_abnormal_circadian_rhythm | 0.68158560 |
| 153 | MP0002638_abnormal_pupillary_reflex | 0.67817547 |
| 154 | MP0006054_spinal_hemorrhage | 0.66955038 |
| 155 | MP0001191_abnormal_skin_condition | 0.66160368 |
| 156 | MP0002138_abnormal_hepatobiliary_system | 0.65436129 |
| 157 | MP0005360_urolithiasis | 0.63172444 |
| 158 | MP0005266_abnormal_metabolism | 0.63043597 |
| 159 | MP0001790_abnormal_immune_system | 0.63034211 |
| 160 | MP0005387_immune_system_phenotype | 0.63034211 |
| 161 | MP0001119_abnormal_female_reproductive | 0.62653925 |
| 162 | MP0005332_abnormal_amino_acid | 0.62565327 |
| 163 | MP0005220_abnormal_exocrine_pancreas | 0.62128461 |
| 164 | MP0003252_abnormal_bile_duct | 0.61787654 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Reduced antithrombin III activity (HP:0001976) | 9.25642955 |
| 2 | Type I transferrin isoform profile (HP:0003642) | 8.53056532 |
| 3 | Abnormal protein N-linked glycosylation (HP:0012347) | 6.25582077 |
| 4 | Abnormal protein glycosylation (HP:0012346) | 6.25582077 |
| 5 | Abnormal glycosylation (HP:0012345) | 6.25582077 |
| 6 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 6.25582077 |
| 7 | Annular pancreas (HP:0001734) | 3.86837815 |
| 8 | Abnormal number of erythroid precursors (HP:0012131) | 3.86489637 |
| 9 | Acute myeloid leukemia (HP:0004808) | 3.81413721 |
| 10 | Abnormality of cells of the erythroid lineage (HP:0012130) | 3.75715688 |
| 11 | Increased serum pyruvate (HP:0003542) | 3.72265354 |
| 12 | Abnormality of glycolysis (HP:0004366) | 3.60059548 |
| 13 | Thoracic kyphosis (HP:0002942) | 3.55254294 |
| 14 | Thrombocytosis (HP:0001894) | 3.44429508 |
| 15 | Hypothermia (HP:0002045) | 3.37902063 |
| 16 | Thyroid-stimulating hormone excess (HP:0002925) | 3.37264410 |
| 17 | Volvulus (HP:0002580) | 3.32031203 |
| 18 | Aplastic anemia (HP:0001915) | 3.31240776 |
| 19 | Abnormality of methionine metabolism (HP:0010901) | 3.30874262 |
| 20 | Severe visual impairment (HP:0001141) | 3.16168647 |
| 21 | Abnormality of the intrinsic pathway (HP:0010989) | 3.07063344 |
| 22 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 3.04886831 |
| 23 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 3.04406216 |
| 24 | Myelodysplasia (HP:0002863) | 3.03480219 |
| 25 | Nephroblastoma (Wilms tumor) (HP:0002667) | 2.96833614 |
| 26 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.94658160 |
| 27 | Papillary thyroid carcinoma (HP:0002895) | 2.93203993 |
| 28 | Hepatic necrosis (HP:0002605) | 2.86105703 |
| 29 | Increased hepatocellular lipid droplets (HP:0006565) | 2.85680947 |
| 30 | Multiple enchondromatosis (HP:0005701) | 2.81991483 |
| 31 | Embryonal renal neoplasm (HP:0011794) | 2.79746104 |
| 32 | Exertional dyspnea (HP:0002875) | 2.78535640 |
| 33 | Abnormality of the prostate (HP:0008775) | 2.77936424 |
| 34 | Ocular albinism (HP:0001107) | 2.76748438 |
| 35 | Ankle contracture (HP:0006466) | 2.76490576 |
| 36 | Hepatocellular necrosis (HP:0001404) | 2.75624279 |
| 37 | Reticulocytopenia (HP:0001896) | 2.75495863 |
| 38 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.73034835 |
| 39 | Abnormality of the thoracic spine (HP:0100711) | 2.68027922 |
| 40 | Prolonged partial thromboplastin time (HP:0003645) | 2.67459157 |
| 41 | Progressive external ophthalmoplegia (HP:0000590) | 2.67329877 |
| 42 | Thyroid carcinoma (HP:0002890) | 2.61258428 |
| 43 | Obstructive lung disease (HP:0006536) | 2.60885405 |
| 44 | Chronic obstructive pulmonary disease (HP:0006510) | 2.60885405 |
| 45 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.58490862 |
| 46 | Lipid accumulation in hepatocytes (HP:0006561) | 2.58178749 |
| 47 | B lymphocytopenia (HP:0010976) | 2.55339526 |
| 48 | Late onset (HP:0003584) | 2.54074774 |
| 49 | Rhabdomyosarcoma (HP:0002859) | 2.53076454 |
| 50 | Capillary hemangiomas (HP:0005306) | 2.47736990 |
| 51 | Cortical visual impairment (HP:0100704) | 2.46804051 |
| 52 | Spinal canal stenosis (HP:0003416) | 2.45041307 |
| 53 | Pancreatic islet-cell hyperplasia (HP:0004510) | 2.45004516 |
| 54 | Abnormality of magnesium homeostasis (HP:0004921) | 2.43141724 |
| 55 | IgM deficiency (HP:0002850) | 2.42560619 |
| 56 | Birth length less than 3rd percentile (HP:0003561) | 2.38796992 |
| 57 | Gonadotropin excess (HP:0000837) | 2.37934008 |
| 58 | Renal Fanconi syndrome (HP:0001994) | 2.35409819 |
| 59 | Recurrent abscess formation (HP:0002722) | 2.33405466 |
| 60 | Pulmonary fibrosis (HP:0002206) | 2.32979962 |
| 61 | Microretrognathia (HP:0000308) | 2.32945070 |
| 62 | Premature ovarian failure (HP:0008209) | 2.28828938 |
| 63 | Iris hypopigmentation (HP:0007730) | 2.27415027 |
| 64 | Fatigue (HP:0012378) | 2.27355414 |
| 65 | Myositis (HP:0100614) | 2.26407950 |
| 66 | Abnormality of B cell number (HP:0010975) | 2.25669303 |
| 67 | Autoimmune hemolytic anemia (HP:0001890) | 2.24639449 |
| 68 | Duodenal stenosis (HP:0100867) | 2.24338510 |
| 69 | Small intestinal stenosis (HP:0012848) | 2.24338510 |
| 70 | Exercise-induced muscle cramps (HP:0003710) | 2.21667560 |
| 71 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 2.19855446 |
| 72 | Ankyloglossia (HP:0010296) | 2.19464453 |
| 73 | Stomatitis (HP:0010280) | 2.18700315 |
| 74 | Petechiae (HP:0000967) | 2.18154167 |
| 75 | Microcytic anemia (HP:0001935) | 2.16804683 |
| 76 | Sex reversal (HP:0012245) | 2.16794388 |
| 77 | Abnormal sex determination (HP:0012244) | 2.16794388 |
| 78 | Meningitis (HP:0001287) | 2.16753153 |
| 79 | Abnormality of secondary sexual hair (HP:0009888) | 2.16737866 |
| 80 | Abnormality of the axillary hair (HP:0100134) | 2.16737866 |
| 81 | Neoplasm of the colon (HP:0100273) | 2.15610138 |
| 82 | Macrocytic anemia (HP:0001972) | 2.15049392 |
| 83 | Mediastinal lymphadenopathy (HP:0100721) | 2.14574602 |
| 84 | Microglossia (HP:0000171) | 2.13315746 |
| 85 | Abnormality of the renal collecting system (HP:0004742) | 2.13262310 |
| 86 | Deep philtrum (HP:0002002) | 2.12693410 |
| 87 | Abnormal lung lobation (HP:0002101) | 2.11778577 |
| 88 | Increased intramyocellular lipid droplets (HP:0012240) | 2.11444267 |
| 89 | Acute lymphatic leukemia (HP:0006721) | 2.10694242 |
| 90 | Pancytopenia (HP:0001876) | 2.09636480 |
| 91 | Chromsome breakage (HP:0040012) | 2.08420939 |
| 92 | Limb hypertonia (HP:0002509) | 2.05733840 |
| 93 | Combined immunodeficiency (HP:0005387) | 2.04123328 |
| 94 | Abnormality of T cell physiology (HP:0011840) | 2.03815241 |
| 95 | Agnosia (HP:0010524) | 2.02834981 |
| 96 | Abnormality of the columella (HP:0009929) | 2.02116155 |
| 97 | Increased nuchal translucency (HP:0010880) | 2.01654170 |
| 98 | Microvesicular hepatic steatosis (HP:0001414) | 2.01492758 |
| 99 | Oral leukoplakia (HP:0002745) | 1.99256102 |
| 100 | Palpitations (HP:0001962) | 1.98660263 |
| 101 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 1.96910517 |
| 102 | Progressive muscle weakness (HP:0003323) | 1.96241480 |
| 103 | Vacuolated lymphocytes (HP:0001922) | 1.96052277 |
| 104 | Abnormality of the preputium (HP:0100587) | 1.95976612 |
| 105 | Cerebral edema (HP:0002181) | 1.95704862 |
| 106 | Clubbing of toes (HP:0100760) | 1.95651685 |
| 107 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 1.95439272 |
| 108 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 1.95439272 |
| 109 | Recurrent bacterial skin infections (HP:0005406) | 1.93788403 |
| 110 | Cutaneous melanoma (HP:0012056) | 1.93054782 |
| 111 | Lower limb hyperreflexia (HP:0002395) | 1.93042801 |
| 112 | Hypoglycemic coma (HP:0001325) | 1.92076773 |
| 113 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 1.91876109 |
| 114 | Short middle phalanx of the 5th finger (HP:0004220) | 1.91657757 |
| 115 | Abnormal spermatogenesis (HP:0008669) | 1.91319166 |
| 116 | Cystic hygroma (HP:0000476) | 1.91091539 |
| 117 | Abnormality of the anterior horn cell (HP:0006802) | 1.90962945 |
| 118 | Degeneration of anterior horn cells (HP:0002398) | 1.90962945 |
| 119 | Posterior subcapsular cataract (HP:0007787) | 1.90495514 |
| 120 | Abnormal rod and cone electroretinograms (HP:0008323) | 1.90411615 |
| 121 | Megaloblastic anemia (HP:0001889) | 1.89049637 |
| 122 | Breast carcinoma (HP:0003002) | 1.88519021 |
| 123 | Neoplasm of the small intestine (HP:0100833) | 1.88330613 |
| 124 | Stenosis of the external auditory canal (HP:0000402) | 1.88049897 |
| 125 | Generalized aminoaciduria (HP:0002909) | 1.87607893 |
| 126 | Meckel diverticulum (HP:0002245) | 1.87266606 |
| 127 | Cafe-au-lait spot (HP:0000957) | 1.87086261 |
| 128 | Increased muscle lipid content (HP:0009058) | 1.86808966 |
| 129 | Knee flexion contracture (HP:0006380) | 1.86161458 |
| 130 | Neuroblastic tumors (HP:0004376) | 1.85842182 |
| 131 | Peripheral primitive neuroectodermal neoplasm (HP:0030067) | 1.85842182 |
| 132 | Neuroblastoma (HP:0003006) | 1.85842182 |
| 133 | Primitive neuroectodermal tumor (HP:0030065) | 1.85842182 |
| 134 | Pallor (HP:0000980) | 1.85431313 |
| 135 | Abnormality of alanine metabolism (HP:0010916) | 1.85425564 |
| 136 | Hyperalaninemia (HP:0003348) | 1.85425564 |
| 137 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.85425564 |
| 138 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 1.85249124 |
| 139 | Abnormality of chromosome stability (HP:0003220) | 1.84510566 |
| 140 | Abnormality of serum amino acid levels (HP:0003112) | 1.83951051 |
| 141 | Biliary tract neoplasm (HP:0100574) | 1.83541197 |
| 142 | Proximal tubulopathy (HP:0000114) | 1.83369268 |
| 143 | Central scotoma (HP:0000603) | 1.82981471 |
| 144 | Respiratory difficulties (HP:0002880) | 1.82853450 |
| 145 | Ovarian neoplasm (HP:0100615) | 1.82637104 |
| 146 | Neoplasm of the adrenal gland (HP:0100631) | 1.81806070 |
| 147 | Eczematoid dermatitis (HP:0000976) | 1.81519337 |
| 148 | Bone marrow hypocellularity (HP:0005528) | 1.81216050 |
| 149 | Duplicated collecting system (HP:0000081) | 1.80939104 |
| 150 | Abnormality of the common coagulation pathway (HP:0010990) | 1.80845764 |
| 151 | Abnormality of the duodenum (HP:0002246) | 1.79480565 |
| 152 | Syringomyelia (HP:0003396) | 1.78219642 |
| 153 | Spinal cord lesions (HP:0100561) | 1.78219642 |
| 154 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 1.75250522 |
| 155 | Abnormality of the ileum (HP:0001549) | 1.75085364 |
| 156 | Dyschromatopsia (HP:0007641) | 1.74891447 |
| 157 | Premature graying of hair (HP:0002216) | 1.72428142 |
| 158 | Neoplasm of the rectum (HP:0100743) | 1.72278678 |
| 159 | Neutropenia (HP:0001875) | 1.72168869 |
| 160 | Abnormal biliary tract morphology (HP:0012440) | 1.72110305 |
| 161 | Abnormality of oral frenula (HP:0000190) | 1.72079528 |
| 162 | Increased serum lactate (HP:0002151) | 1.72025625 |
| 163 | Abnormal auditory evoked potentials (HP:0006958) | 1.71112728 |
| 164 | Asymmetry of the thorax (HP:0001555) | 1.70876282 |
| 165 | Severe combined immunodeficiency (HP:0004430) | 1.70474737 |
| 166 | Symptomatic seizures (HP:0011145) | 1.70114341 |
| 167 | Flat occiput (HP:0005469) | 1.70010964 |
| 168 | Attenuation of retinal blood vessels (HP:0007843) | 1.69623711 |
| 169 | Granulocytopenia (HP:0001913) | 1.69480806 |
| 170 | Chest pain (HP:0100749) | 1.69316581 |
| 171 | Secondary amenorrhea (HP:0000869) | 1.69017991 |
| 172 | Split foot (HP:0001839) | 1.68763442 |
| 173 | Poor head control (HP:0002421) | 1.68030124 |
| 174 | Homocystinuria (HP:0002156) | 1.67821594 |
| 175 | Abnormality of homocysteine metabolism (HP:0010919) | 1.67821594 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TNIK | 7.74767615 |
| 2 | NLK | 4.62895116 |
| 3 | STK16 | 3.94092875 |
| 4 | CAMKK2 | 3.47812011 |
| 5 | MST4 | 3.08403851 |
| 6 | PBK | 2.97038358 |
| 7 | MKNK2 | 2.91124162 |
| 8 | NEK1 | 2.90692044 |
| 9 | WEE1 | 2.77285276 |
| 10 | TTK | 2.76446967 |
| 11 | TEC | 2.47000552 |
| 12 | TSSK6 | 2.42623790 |
| 13 | FES | 2.23073773 |
| 14 | IRAK4 | 2.13971069 |
| 15 | MKNK1 | 2.12940012 |
| 16 | KIT | 1.94014743 |
| 17 | PIM2 | 1.87710754 |
| 18 | STK3 | 1.85350001 |
| 19 | IRAK3 | 1.82629516 |
| 20 | BUB1 | 1.80965459 |
| 21 | CDC7 | 1.80628440 |
| 22 | ERBB3 | 1.73867842 |
| 23 | PLK3 | 1.73445420 |
| 24 | NME2 | 1.67637782 |
| 25 | VRK1 | 1.61970835 |
| 26 | SCYL2 | 1.59974617 |
| 27 | FLT3 | 1.53276028 |
| 28 | BMPR2 | 1.52882870 |
| 29 | TESK2 | 1.52879881 |
| 30 | NUAK1 | 1.52077690 |
| 31 | EEF2K | 1.50792319 |
| 32 | TRIM28 | 1.43627123 |
| 33 | CDK6 | 1.33673997 |
| 34 | ACVR1B | 1.30118693 |
| 35 | ZAK | 1.28956116 |
| 36 | LATS1 | 1.25786650 |
| 37 | MAP3K13 | 1.25779973 |
| 38 | BRD4 | 1.25685396 |
| 39 | TGFBR1 | 1.25125081 |
| 40 | BTK | 1.23075503 |
| 41 | YES1 | 1.21477340 |
| 42 | MAP3K12 | 1.17107858 |
| 43 | SRPK1 | 1.15959644 |
| 44 | BMPR1B | 1.08839660 |
| 45 | PDK2 | 1.08378191 |
| 46 | STK39 | 1.07558844 |
| 47 | BRSK2 | 1.06319053 |
| 48 | EIF2AK1 | 1.05135269 |
| 49 | VRK2 | 1.04487439 |
| 50 | MUSK | 1.01689653 |
| 51 | TLK1 | 0.93331277 |
| 52 | CDK7 | 0.93212632 |
| 53 | PIM1 | 0.91792938 |
| 54 | MAP2K3 | 0.90300280 |
| 55 | PASK | 0.90113365 |
| 56 | TAF1 | 0.89785343 |
| 57 | TAOK2 | 0.89581976 |
| 58 | PLK4 | 0.84875787 |
| 59 | MST1R | 0.84317057 |
| 60 | CHEK1 | 0.83505538 |
| 61 | RAF1 | 0.83425835 |
| 62 | ATM | 0.83008150 |
| 63 | CDK4 | 0.81943063 |
| 64 | CAMKK1 | 0.81800050 |
| 65 | PRPF4B | 0.81626770 |
| 66 | TESK1 | 0.80133771 |
| 67 | KDR | 0.79189248 |
| 68 | CDK19 | 0.79125073 |
| 69 | SYK | 0.79021246 |
| 70 | TRPM7 | 0.77351778 |
| 71 | * EIF2AK3 | 0.77257584 |
| 72 | DYRK3 | 0.76614433 |
| 73 | ATR | 0.76065190 |
| 74 | MAP4K1 | 0.75591717 |
| 75 | NME1 | 0.74479872 |
| 76 | BCR | 0.74407990 |
| 77 | BCKDK | 0.74127893 |
| 78 | LYN | 0.73762205 |
| 79 | CCNB1 | 0.73509765 |
| 80 | STK24 | 0.73052491 |
| 81 | MET | 0.72069345 |
| 82 | MAP3K8 | 0.71890440 |
| 83 | BRAF | 0.71254670 |
| 84 | ZAP70 | 0.71153219 |
| 85 | MAP4K2 | 0.71105096 |
| 86 | RPS6KA4 | 0.70013995 |
| 87 | MAP2K7 | 0.68362929 |
| 88 | ALK | 0.67727775 |
| 89 | CAMK1 | 0.67491366 |
| 90 | NEK6 | 0.66469682 |
| 91 | STK38L | 0.64482714 |
| 92 | CSNK1G1 | 0.64084015 |
| 93 | MAP3K1 | 0.64073809 |
| 94 | CSF1R | 0.60219063 |
| 95 | RPS6KB2 | 0.59902440 |
| 96 | GRK6 | 0.59387599 |
| 97 | ERN1 | 0.59157442 |
| 98 | STK10 | 0.58263987 |
| 99 | PLK1 | 0.57353734 |
| 100 | CDK9 | 0.57014205 |
| 101 | CDK8 | 0.56519133 |
| 102 | NEK9 | 0.56198512 |
| 103 | DAPK1 | 0.54373772 |
| 104 | MELK | 0.54321208 |
| 105 | NEK2 | 0.54164212 |
| 106 | AKT3 | 0.54073229 |
| 107 | AURKB | 0.53129863 |
| 108 | BLK | 0.52761817 |
| 109 | MAPKAPK3 | 0.51885579 |
| 110 | CLK1 | 0.50710422 |
| 111 | SIK3 | 0.50507072 |
| 112 | IKBKB | 0.50435206 |
| 113 | KSR2 | 0.50052001 |
| 114 | TYK2 | 0.49623352 |
| 115 | IKBKE | 0.48338658 |
| 116 | CAMK4 | 0.47639777 |
| 117 | PAK1 | 0.47262600 |
| 118 | AURKA | 0.46777484 |
| 119 | MATK | 0.46658977 |
| 120 | KSR1 | 0.45254078 |
| 121 | UHMK1 | 0.44557311 |
| 122 | TAOK3 | 0.44423955 |
| 123 | CDK1 | 0.43375009 |
| 124 | MAPKAPK5 | 0.43057616 |
| 125 | FGFR1 | 0.42474179 |
| 126 | * CDK2 | 0.42057549 |
| 127 | BRSK1 | 0.41821380 |
| 128 | HIPK2 | 0.41548210 |
| 129 | CSNK2A1 | 0.39439187 |
| 130 | STK4 | 0.38073358 |
| 131 | * EIF2AK2 | 0.37639462 |
| 132 | CHEK2 | 0.37593501 |
| 133 | MAPK4 | 0.37452714 |
| 134 | PAK4 | 0.37423104 |
| 135 | ADRBK2 | 0.37124226 |
| 136 | MAP3K11 | 0.36875226 |
| 137 | TXK | 0.36580481 |
| 138 | ABL2 | 0.35508053 |
| 139 | CSNK2A2 | 0.35183784 |
| 140 | LCK | 0.35015029 |
| 141 | JAK3 | 0.34284342 |
| 142 | MYLK | 0.34188956 |
| 143 | LATS2 | 0.33578567 |
| 144 | MAP3K2 | 0.32943485 |
| 145 | ITK | 0.32382338 |
| 146 | MAP3K14 | 0.31613486 |
| 147 | PRKCI | 0.31032568 |
| 148 | CSK | 0.30998413 |
| 149 | CASK | 0.29725924 |
| 150 | PIK3CG | 0.29623361 |
| 151 | ERBB4 | 0.29443813 |
| 152 | IRAK1 | 0.28097374 |
| 153 | RPS6KB1 | 0.25376861 |
| 154 | TBK1 | 0.22965028 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | DNA replication_Homo sapiens_hsa03030 | 5.79296675 |
| 2 | Mismatch repair_Homo sapiens_hsa03430 | 3.75137023 |
| 3 | Ribosome_Homo sapiens_hsa03010 | 3.68319939 |
| 4 | Protein export_Homo sapiens_hsa03060 | 3.13116856 |
| 5 | Base excision repair_Homo sapiens_hsa03410 | 2.89916417 |
| 6 | Homologous recombination_Homo sapiens_hsa03440 | 2.82517256 |
| 7 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 2.81429952 |
| 8 | Proteasome_Homo sapiens_hsa03050 | 2.69328409 |
| 9 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.57932603 |
| 10 | Nucleotide excision repair_Homo sapiens_hsa03420 | 2.42919851 |
| 11 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 2.39825565 |
| 12 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.25554087 |
| 13 | Spliceosome_Homo sapiens_hsa03040 | 2.09098869 |
| 14 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 2.04720095 |
| 15 | Other glycan degradation_Homo sapiens_hsa00511 | 2.03308040 |
| 16 | RNA polymerase_Homo sapiens_hsa03020 | 1.99274500 |
| 17 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.98394041 |
| 18 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.79164954 |
| 19 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.75777085 |
| 20 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.74501349 |
| 21 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.70209914 |
| 22 | Thyroid cancer_Homo sapiens_hsa05216 | 1.67047967 |
| 23 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.64807856 |
| 24 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 1.64217103 |
| 25 | Cell cycle_Homo sapiens_hsa04110 | 1.53930575 |
| 26 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.47283807 |
| 27 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.44733193 |
| 28 | Carbon metabolism_Homo sapiens_hsa01200 | 1.43494231 |
| 29 | Basal transcription factors_Homo sapiens_hsa03022 | 1.39875344 |
| 30 | Purine metabolism_Homo sapiens_hsa00230 | 1.39826479 |
| 31 | RNA transport_Homo sapiens_hsa03013 | 1.37703987 |
| 32 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.37628956 |
| 33 | Renin-angiotensin system_Homo sapiens_hsa04614 | 1.36896206 |
| 34 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.35052291 |
| 35 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.28887852 |
| 36 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.24937873 |
| 37 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.24679880 |
| 38 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.24514754 |
| 39 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 1.22803428 |
| 40 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.20954403 |
| 41 | RNA degradation_Homo sapiens_hsa03018 | 1.20534425 |
| 42 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.16105481 |
| 43 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.08679218 |
| 44 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.02500808 |
| 45 | Leishmaniasis_Homo sapiens_hsa05140 | 1.01948901 |
| 46 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 1.01513251 |
| 47 | Oocyte meiosis_Homo sapiens_hsa04114 | 1.01110459 |
| 48 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.00204175 |
| 49 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.98069764 |
| 50 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.93817405 |
| 51 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.93199291 |
| 52 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.92167911 |
| 53 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.91106864 |
| 54 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.90219404 |
| 55 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.89425430 |
| 56 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.87977512 |
| 57 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.87027254 |
| 58 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.86790539 |
| 59 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.85724342 |
| 60 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.85261977 |
| 61 | Circadian rhythm_Homo sapiens_hsa04710 | 0.85205905 |
| 62 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.81526430 |
| 63 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.81280982 |
| 64 | Measles_Homo sapiens_hsa05162 | 0.79711617 |
| 65 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.79154574 |
| 66 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.78093602 |
| 67 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.77319049 |
| 68 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.76026091 |
| 69 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.70034430 |
| 70 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.67790474 |
| 71 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.67683681 |
| 72 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.66408295 |
| 73 | Legionellosis_Homo sapiens_hsa05134 | 0.63624901 |
| 74 | Asthma_Homo sapiens_hsa05310 | 0.62905145 |
| 75 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.62571575 |
| 76 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.62100993 |
| 77 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.62021262 |
| 78 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.60424971 |
| 79 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.60045794 |
| 80 | Galactose metabolism_Homo sapiens_hsa00052 | 0.58839177 |
| 81 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.58115951 |
| 82 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.57806802 |
| 83 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.55513754 |
| 84 | Sulfur relay system_Homo sapiens_hsa04122 | 0.54266240 |
| 85 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.53679992 |
| 86 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.52471642 |
| 87 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.50838047 |
| 88 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.50816508 |
| 89 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.49107120 |
| 90 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.48797200 |
| 91 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.48274845 |
| 92 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.48262818 |
| 93 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.47131684 |
| 94 | Metabolic pathways_Homo sapiens_hsa01100 | 0.46615717 |
| 95 | Pertussis_Homo sapiens_hsa05133 | 0.46446077 |
| 96 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.46055313 |
| 97 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.44119741 |
| 98 | Lysine degradation_Homo sapiens_hsa00310 | 0.43267185 |
| 99 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.42941391 |
| 100 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.42845373 |
| 101 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.41225353 |
| 102 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.41196704 |
| 103 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.40778386 |
| 104 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.40071108 |
| 105 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.39471308 |
| 106 | Apoptosis_Homo sapiens_hsa04210 | 0.37144163 |
| 107 | Allograft rejection_Homo sapiens_hsa05330 | 0.37115719 |
| 108 | Malaria_Homo sapiens_hsa05144 | 0.36894938 |
| 109 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.36451329 |
| 110 | Hepatitis B_Homo sapiens_hsa05161 | 0.36424696 |
| 111 | Influenza A_Homo sapiens_hsa05164 | 0.35857419 |
| 112 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.35760215 |
| 113 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.35146228 |
| 114 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.34396228 |
| 115 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.34034217 |
| 116 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.33511802 |
| 117 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.33110897 |
| 118 | Lysosome_Homo sapiens_hsa04142 | 0.32722037 |
| 119 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.32465724 |
| 120 | Tuberculosis_Homo sapiens_hsa05152 | 0.31921477 |
| 121 | Phagosome_Homo sapiens_hsa04145 | 0.31872767 |
| 122 | HTLV-I infection_Homo sapiens_hsa05166 | 0.31872701 |
| 123 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.30943114 |
| 124 | Peroxisome_Homo sapiens_hsa04146 | 0.30400904 |
| 125 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.28010200 |
| 126 | Parkinsons disease_Homo sapiens_hsa05012 | 0.27272224 |
| 127 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.26869229 |
| 128 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.26651192 |
| 129 | Prostate cancer_Homo sapiens_hsa05215 | 0.26538647 |
| 130 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.26116360 |
| 131 | Salmonella infection_Homo sapiens_hsa05132 | 0.26007977 |
| 132 | Huntingtons disease_Homo sapiens_hsa05016 | 0.24431043 |
| 133 | Shigellosis_Homo sapiens_hsa05131 | 0.24414093 |
| 134 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.24191553 |
| 135 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.23722316 |
| 136 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.22512108 |
| 137 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.19764379 |
| 138 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.17982530 |

